(BMY) - Analyzing Bristol-Myers Squibb's Short Interest
Portfolio Pulse from Benzinga Insights
Bristol-Myers Squibb's (NYSE:BMY) short percent of float has fallen 8.05% since its last report, with 16.64 million shares sold short, which is 0.8% of all regular shares available for trading. This decrease in short interest could signal a more bullish market sentiment towards the stock. However, it does not necessarily mean that the stock price will rise in the near term. Compared to its peers, Bristol-Myers Squibb has less short interest.
August 15, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Bristol-Myers Squibb's short percent of float has decreased, indicating a more bullish sentiment. However, this doesn't guarantee a rise in stock price.
A decrease in short interest can signal a more bullish sentiment towards a stock. However, it does not necessarily mean that the stock price will rise in the near term. Therefore, while the news is highly relevant to Bristol-Myers Squibb, its impact on the stock price is uncertain.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100